424 related articles for article (PubMed ID: 19168812)
1. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
Aburahma SK; Al-Khateeb T; Alrefai A; Amarin Z
J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome.
Bandeira ID; Jagersbacher JG; Barretto TL; Santos CV; Lucena R
Muscle Nerve; 2017 Aug; 56(2):E10-E11. PubMed ID: 28187499
[No Abstract] [Full Text] [Related]
3. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
Papapetropoulos S; Singer C
Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin A in the treatment of concomitant strabismus in children].
Oleszczyńska-Prost E
Klin Oczna; 2004; 106(1-2):64-7. PubMed ID: 15218768
[TBL] [Abstract][Full Text] [Related]
6. Schwartz-Jampel syndrome: surgical management of the myotonia-induced blepharospasm and acquired ptosis after failure with botulinum toxin A injections.
Morrison DA; Mellington FB; Hamada S; Moore AT
Ophthalmic Plast Reconstr Surg; 2006; 22(1):57-9. PubMed ID: 16418670
[TBL] [Abstract][Full Text] [Related]
7. A case of Schwartz-Jampel syndrome with cleft palate.
Abdel-Aziz M; Azab NA
Int J Pediatr Otorhinolaryngol; 2009 Nov; 73(11):1601-3. PubMed ID: 19733405
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A injection for children with spastic cerebral palsy.
YaJie W; BaoQin G
Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
[No Abstract] [Full Text] [Related]
9. Schwartz-Jampel syndrome: three pediatric case reports.
Yapicioğlu H; Satar M; Yildizdaş D; Narli N; Suleymanova D; Tutak E
Genet Couns; 2003; 14(3):353-8. PubMed ID: 14577682
[TBL] [Abstract][Full Text] [Related]
10. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
Singer C; Papapetropoulos S; Farronay O
Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
[TBL] [Abstract][Full Text] [Related]
11. [Schwartz-Jampel syndrome (osteochondromuscular dystrophy)].
Ben Becher S; el Mabrouk J; Debbiche A; Hammou A; Ghram N; Makni S; Boudhina T
Arch Fr Pediatr; 1992 Nov; 49(9):799-802. PubMed ID: 1300968
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin A in the treatment of congenital nystagmus in children].
Oleszczyńska-Prost E
Klin Oczna; 2004; 106(4-5):625-8. PubMed ID: 15646482
[TBL] [Abstract][Full Text] [Related]
13. Treatment of facial chromhidrosis with botulinum toxin type A.
Matarasso SL
J Am Acad Dermatol; 2005 Jan; 52(1):89-91. PubMed ID: 15627085
[TBL] [Abstract][Full Text] [Related]
14. Resistance to rocuronium in a child with Schwartz-Jampel syndrome type 1 B.
Eikermann M; Bredendiek M; Schaper J; Hövel M; Peters J
Neuropediatrics; 2002 Feb; 33(1):43-6. PubMed ID: 11930277
[TBL] [Abstract][Full Text] [Related]
15. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin.
Sabesan T
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):588-90. PubMed ID: 18346825
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin in infantile cerebral palsy].
Póo P; Galván-Manso M; Casartelli MJ; López-Casas J; Gassió-Subirats RM; Blanco C; Terricabras-Carol L
Rev Neurol; 2008; 47 Suppl 1():S21-4. PubMed ID: 18767013
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia].
Ruiz Huete C; Bermejo P
Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
Song PC; Schwartz J; Blitzer A
Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
[TBL] [Abstract][Full Text] [Related]
20. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
Weigl DM; Arbel N
Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
